The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis
Abstract
Individuals with cystic fibrosis (CF) have an increased risk for gallbladder abnormalities and biliary tract disease, but the reported incidence of these manifestations of CF varies widely in the literature. With the approval of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA), increasing numbers of CF patients have been initiated on highly effective cystic fibrosis transmembrane regulator (CFTR) modulator therapy. While elevations in hepatic panel are known potential side effects of CFTR modulators, there have been no published cases of biliary disease or acute cholecystitis attributed to these medications. In this case series, we describe seven patients at two adult CF centers with biliary colic shortly after initiation with ELX/TEZ/IVA, six of whom required cholecystectomy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, acute cholecystitis after initiation of caftor therapy has been reported, presumably due to increased clearance of sludge with enhanced bile flow. 71”
From The contemporary epidemiology, causes, and management of drug-induced liver injury (2026) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Middleton, P. G., Mall, M. A., Dřevínek, P., Lands, L. C., McKone, E. F., Polineni, D., Ramsey, B. W., Taylor-Cousar, J. L., Tullis, E., Vermeulen, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908639 · Cited by 2,198
Heijerman, H. G. M., McKone, E. F., Downey, D. G., Van Braeckel, E., Rowe, S. M., Tullis, E., Mall, M. A., Welter, J. J., Ramsey, B. W., McKee, C. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32597-8 · Cited by 1,414
Research works printed but not linked: 11
- Assis, 2017, Gallbladder and bile duct disease in cystic fibrosis, J Cyst Fibros, 16, S62, 10.1016/j.jcf.2017.07.006 · DOI
- Colombo, 1998, Liver and biliary problems in cystic fibrosis, Semin Liver Dis, 18, 227, 10.1055/s-2007-1007159 · DOI
- Curry, 2005, The gallbladder and biliary tract in cystic fibrosis, Curr Gastroenterol Rep, 7, 147, 10.1007/s11894-005-0053-6 · doi:10.1007/s11894-005-0053-6
- Ooi, 2016, Cystic fibrosis from the gastroenterologist's perspective, Nat Rev Gastroeneterol Hepatol, 13, 175, 10.1038/nrgastro.2015.226 · DOI · Paper page
- Moyer, 2009, Hepatobiliary disease in patients with cystic fibrosis, Curr Opin Gastronenterol, 25, 272, 10.1097/MOG.0b013e3283298865 · doi:10.1097/mog.0b013e3283298865
- Cogliandolo, 2011, Postoperative outcomes and quality of life in patients with cystic fibrosis undergoing laparoscopic cholecystectomy: a retrospective study, Surg Laparosc Endosc Percutan Tech, 21, 179, 10.1097/SLE.0b013e318219a2b5 · doi:10.1097/sle.0b013e318219a2b5
- Stern, 1986, Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis, J Pediatr Gastronenterol Nutr, 5, 35
- Snyder, 1989, Operative therapy of gallbladder disease in patients with cystic fibrosis, Am J Surg, 157, 557, 10.1016/0002-9610(89)90698-3 · doi:10.1016/0002-9610(89)90698-3
- McGrath, 1997, Laparoscopic cholecystectomy in adult cystic fibrosis patients, Ir J Med Sci, 166, 70, 10.1007/BF02944189 · doi:10.1007/bf02944189
- Cohn, 1993, Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells, Gastroenterology, 105, 1857, 10.1016/0016-5085(93)91085-V · DOI · Paper page
- Sakiani, 2019, Hepatic manifestations of cystic fibrosis, Clin Liver Dis, 23, 263, 10.1016/j.cld.2018.12.008 · DOI
Cited by
New Therapies to Correct the Cystic Fibrosis Basic Defect
Bergeron, C., & Cantin, A. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126193 · Cited by 22
The contemporary epidemiology, causes, and management of drug-induced liver injury
Swanson, L., & Fontana, R. J. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000001011
Metadata
- Authors
- Safirstein, J., Grant, J. J., Clausen, E., Savant, D., Dezube, R., & Hong, G.
- Venue
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 20
- Issue
- 3
- Pages
- 506-510
- ISSN
- 1569-1993
- Cited by
- 33
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 730 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.